Hangzhou AGS MedTech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	664.92	632.86	506.09	368.92	305.1	171.55
Other Revenue	3.78	3.78	2.65	2.2	0.37	0.4
Revenue	668.7	636.63	508.75	371.11	305.47	171.95
Revenue Growth (YoY)	13.32%	25.14%	37.09%	21.49%	77.64%	-5.95%
Cost of Revenue	197.22	180.84	149.86	119.38	108.54	68.04
Gross Profit	471.48	455.79	358.89	251.73	196.92	103.92
Selling, General & Admin	123.18	108.89	95.38	66.59	53	37.41
Research & Development	74.93	59.21	41.25	31.46	24.19	18.48
Other Operating Expenses	7.94	6.09	1.39	3.29	2.43	1.01
Operating Expenses	208.31	173.69	140.17	101.63	79.83	56.67
Operating Income	263.17	282.11	218.72	150.1	117.09	47.25
Interest Expense	-0.08	-	-	-	-	-
Interest & Investment Income	49.44	55.23	28.91	2.59	2.52	2.44
Currency Exchange Gain (Loss)	0.32	0.32	0.69	11.1	-4.24	-5.16
Other Non Operating Income (Expenses)	1.1	1.19	-1.05	-0.84	-0.14	-0.09
EBT Excluding Unusual Items	313.96	338.85	247.28	162.95	115.23	44.43
Gain (Loss) on Sale of Investments	2.75	2.08	0.41	-7.19	1.09	-
Gain (Loss) on Sale of Assets	0.04	-0.19	-0.35	-0.14	-0.01	-
Asset Writedown	2.69	-0.02	-0.46	-0	-0.14	-
Other Unusual Items	2.91	2.87	4.78	9.94	3.79	6.6
Pretax Income	322.36	343.6	251.67	165.56	119.97	51.03
Income Tax Expense	49.41	50.21	34.43	20.6	15.17	5.8
Net Income	272.95	293.39	217.24	144.96	104.8	45.23
Net Income to Common	272.95	293.39	217.24	144.96	104.8	45.23
Net Income Growth	0.53%	35.06%	49.86%	38.32%	131.68%	-17.36%
Shares Outstanding (Basic)	81	81	73	61	61	61
Shares Outstanding (Diluted)	81	81	73	61	61	61
Shares Change (YoY)	0.35%	11.02%	19.46%	-	-	-0.10%
EPS (Basic)	3.37	3.64	2.99	2.39	1.72	0.74
EPS (Diluted)	3.37	3.64	2.99	2.39	1.72	0.74
EPS Growth	0.18%	21.65%	25.44%	38.60%	131.71%	-17.46%
Free Cash Flow	149.56	266.19	169.88	96.26	102.59	25.11
Free Cash Flow Per Share	1.85	3.30	2.34	1.58	1.69	0.41
Dividend Per Share	1.373	1.373	1.036	0.543	-	-
Dividend Growth	32.62%	32.62%	90.77%	-	-	-
Gross Margin	70.51%	71.59%	70.54%	67.83%	64.47%	60.43%
Operating Margin	39.36%	44.31%	42.99%	40.45%	38.33%	27.48%
Profit Margin	40.82%	46.09%	42.70%	39.06%	34.31%	26.31%
Free Cash Flow Margin	22.36%	41.81%	33.39%	25.94%	33.59%	14.60%
EBITDA	272.18	290.07	225.29	154.82	121.17	50.61
EBITDA Margin	40.70%	45.56%	44.28%	41.72%	39.67%	29.43%
D&A For EBITDA	9.01	7.96	6.56	4.72	4.07	3.36
EBIT	263.17	282.11	218.72	150.1	117.09	47.25
EBIT Margin	39.36%	44.31%	42.99%	40.45%	38.33%	27.48%
Effective Tax Rate	15.33%	14.61%	13.68%	12.44%	12.64%	11.36%
Revenue as Reported	668.7	636.63	508.75	371.11	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.